KFDA likely to assess clinical effectiveness of new chemically modified medicines

Published: 2008-09-11 07:00:00

Updated: 2008-09-11 07:00:00

The Korea Food and Drug Administration is expected to evaluate the clinical effectiveness of new chemically modified medicines with an improved dosage and administration in the process of granting its market authorization, according to the Ministry of Health, Welfare and Family Affairs.

If th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK